找化学品上960化工网!
960化工网

纳他霉素 | 7681-93-8

纳他霉素
Natamycin
7681-93-8
C33H47NO13
665.7252
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:纳他霉素结构式
5284447
纳他霉素价格
简介
纳他霉素——近白色或奶油黄色结晶粉末。是一种无臭、无味,低剂量且安全性高的食品防腐剂。纳他霉素(Natamycin),是由纳他链霉菌受控发酵制得一种白色至乳白色的无臭无味的结晶粉末,通常以烯醇式结构存在。它的作用机理是与真菌的麦角甾醇以及其他甾醇基团结合,阻遏麦角甾醇生物合成,从而使细胞膜畸变,最终导致渗漏,引起细胞死亡。在焙烤食品用纳他霉素对面团进行表面处理,有明显的延长保质期作用。
名称和标识符
MDL MFCD00135085
InChIKey NCXMLFZGDNKEPB-BFDQZDGFSA-N
Inchi 1S/C33H47NO13/c1-18-10-8-6-4-3-5-7-9-11-21(45-32-30(39)28(34)29(38)19(2)44-32)15-25-27(31(40)41)22(36)17-33(42,47-25)16-20(35)14-24-23(46-24)12-13-26(37)43-18/h3-9,11-13,18-25,27-30,32,35-36,38-39,42H,10,14-17,34H2,1-2H3,(H,40,41)/b4-3+,7-5+,8-6-,11-9+,13-12-/t18-,19-,20+,21+,22+,23-,24-,25+,27-,28+,29-,30+,32+,33-/m1/s1
SMILES O1[C@@]2([H])C([H])([H])[C@]([H])(C([H])=C([H])C([H])=C([H])C([H])=C([H])C([H])=C([H])C([H])([H])[C@@]([H])(C([H])([H])[H])OC(C([H])=C([H])[C@]3([H])[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])[C@@]1(C([H])([H])[C@@]([H])([C@@]2([H])C(=O)O[H])O[H])O[H])O[H])O3)=O)O[C@@]1([H])[C@]([H])([C@]([H])([C@@]([H])([C@@]([H])(C([H])([H])[H])O1)O[H])N([H])[H])O[H] |c:9,13,17,t:21,36|
别名信息
- 中文别名 -
  • 纳他霉素
  • 那他霉素
  • 游霉素
  • 匹马力星
  • 匹马霉素
  • 纳塔霉素
  • 纳他霉素 USP标准品
  • 纳他霉素 标准品
  • 纳他霉素,医药级微粉
  • 钠他霉素
  • 克霉鲜
  • 匹马霉素 标准品
  • 匹马菌素
  • 匹马霉素(分析标准品)
- 英文别名 -
  • Pimaricin, Streptomyces chattanoogensis (1.07360)
  • Natamycin
  • Pimaricin
  • (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-amino-3,6-dideoxy-β-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • (8E,14E,16E,18E,20E)-(1R,3S,5R,7R,12R,22R,24S,25R,26S)-22-(3-amino-3,6-dideoxy-β-D-mannopyranosyloxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatric
  • cl12,625
  • delvocid
  • delvopos
  • mycophyt
  • myprozine
  • natacyn
  • Synogil
  • Pimafucin
  • Natamycinum
  • Natamycine
  • Natamicina
  • Natamycin(Pimaricin)
  • Tennecetin
  • 8O0C852CPO
  • Pimarizin [German]
  • Antibiotic A 5283
  • Natamycinum [INN-Latin]
  • Natamycine [INN-French]
  • Natamicina [INN-Spanish]
  • CL 12625
  • Pimarizin
  • CL 12,625
  • Pimaracin
  • Natamycin [USAN:USP:INN:BAN]
  • NATAMYCIN [WHO-DD]
  • pimaricin
  • CS-1909
  • CHEBI:7488
  • NATAMYCIN [FCC]
  • NATAMYCIN
  • CAS-7681-93-8
  • NATAMYCIN [MART.]
  • DTXSID6021163
  • Delvocid
  • Natamatrix
  • Mycophyt
  • PIMARICIN [JAN]
  • Natafucin
  • 6,11,28-TRIOXATRICYCLO(22.3.1.05,7)OCTACOSA-8,14,16,18,20-PENTAENE-25-CARBOXYLIC ACID, 22-((3-AMINO-3,6-DIDEOXY-.BETA.-D-MANNOPYRANOSYL)OXY)-1,3,26-TRIHYDROXY-12-METHYL-10-OXO-, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-
  • NATAMYCIN (USP-RS)
  • NCGC00016686-01
  • NS00003340
  • (1R*,3S*,5R*,7R*,8E,12R*,14E,16E,18E,20E,22R*,24S*,25R*,26S*)-22-(3-Amino-3,6-dideoxy-beta-D-mannopyranosyloxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.05,7)octacosa- 8,14,16,18,20-pentaene-25-carboxylic acid
  • Natacyn
  • MFCD00135085
  • (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0~5,7~]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • NATAMYCIN [USAN]
  • NATAMYCIN [MI]
  • 7681-93-8
  • EN300-22411493
  • Delvolan
  • Pimaricine
  • 73 - Natamycin (pimaricin) in cheese
  • INS-235
  • EX-A1989
  • E 235
  • (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.0(5,7))octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • myuprozine
  • Pimaricin preparation, ~2.5%, aqueous suspension
  • NATAMYCIN [ORANGE BOOK]
  • (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.0(5,7))octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • Q248466
  • myuprozine
  • Natamycin, United States Pharmacopeia (USP) Reference Standard
  • Pimaricin preparation, ~2.5%, aqueous suspension
  • NATAMYCIN [INN]
  • NATAMYCIN [ORANGE BOOK]
  • NATAMYCIN [USP MONOGRAPH]
  • Q248466
  • 6,11,28-Trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-.beta.-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-
  • Natamycin, United States Pharmacopeia (USP) Reference Standard
  • (5R,7R,24S)-22R-[(3S-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1R,3S,26S-trihydroxy-12R-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8E,14E,16E,18E,20E-pentaene-25R-carboxylic acid
  • NATAMYCIN [INN]
  • Stereoisomer of 22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.0(sup 5,7))octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • NATAMYCIN [USP MONOGRAPH]
  • NATAMYCIN [INCI]
  • 6,11,28-Trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-.beta.-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-
  • CHEMBL1200656
  • (5R,7R,24S)-22R-[(3S-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1R,3S,26S-trihydroxy-12R-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8E,14E,16E,18E,20E-pentaene-25R-carboxylic acid
  • DB00826
  • Stereoisomer of 22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.0(sup 5,7))octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • AKOS030485970
  • NATAMYCIN [INCI]
  • NCGC00373238-02_C33H47NO13_Delvocid
  • CHEMBL1200656
  • Pimaricin
  • Natamycin
  • DB00826
  • AKOS030485970
  • Natamycin, VETRANAL(TM), analytical standard
  • CL-12625
  • NCGC00373238-02_C33H47NO13_Delvocid
  • Tox21_110561
  • Pimaricin
  • Natamycin
  • Natamycin, Pharmaceutical Secondary Standard
  • Certified Reference Material
  • Delvopos
  • Natamycin, VETRANAL(TM), analytical standard
  • DTXCID501473823
  • CL-12625
  • NICOTINAMIDE_ADENINE_DINUCLEOTIDE
  • Tox21_110561
  • Natamycin, Pharmaceutical Secondary Standard
  • Certified Reference Material
  • (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-{[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0,5,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • Delvopos
  • Antibiotic A-5283
  • DTXCID501473823
  • HY-B0133
  • Natamax
  • NICOTINAMIDE_ADENINE_DINUCLEOTIDE
  • EINECS 231-683-5
  • (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-{[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0,5,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • CHEMBL1200656
  • Antibiotic A-5283
  • DTXCID301163
  • DB00826
  • HY-B0133
  • BDBM50370755
  • AKOS030485970
  • Natamax
  • NATAMYCIN (USP MONOGRAPH)
  • NCGC00373238-02_C33H47NO13_Delvocid
  • EINECS 231-683-5
  • NSC-759167
  • Pimaricin
  • Natamycin
  • DTXCID301163
  • SCHEMBL18140
  • Natamycin, VETRANAL(TM), analytical standard
  • BDBM50370755
  • UNII-8O0C852CPO
  • CL-12625
  • NATAMYCIN (USP MONOGRAPH)
  • Natamycin, VETRANAL(TM), analytical standard
  • NATAMYCIN [VANDF]
  • Tox21_110561
  • NSC-759167
  • PMR
  • CL-12625
  • Natamycin, Pharmaceutical Secondary Standard
  • Certified Reference Material
  • SCHEMBL18140
  • Tox21_110561
  • Delvopos
  • (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • DTXCID501473823
  • UNII-8O0C852CPO
  • Natamycin, Pharmaceutical Secondary Standard
  • Certified Reference Material
  • Natajen
  • NATAMYCIN [VANDF]
  • Delvopos
  • NICOTINAMIDE_ADENINE_DINUCLEOTIDE
  • NATAMYCIN [USP-RS]
  • PMR
  • DTXCID501473823
  • NSC 759167
  • (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-{[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0,5,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • Antibiotic A-5283
  • (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • INS NO.235
  • NICOTINAMIDE_ADENINE_DINUCLEOTIDE
  • (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-{[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0,5,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • Natajen
  • HY-B0133
  • Myprozine
  • Antibiotic A-5283
  • Natamax
  • Pimaricin, from Streptomyces chattanoogensis, >=95% (HPLC)
  • NATAMYCIN [USP-RS]
  • HY-B0133
  • NATAMYCIN (MART.)
  • NSC 759167
  • EINECS 231-683-5
  • INS NO.235
  • Natamax
  • DTXCID301163
  • 16-(3-Amino-3,6-didesoxy-beta-D-mannopyranosyloxy)-5,6-epoxy-8,12,14-trihydroxy-26-methyl-2,10-dioxo-1-oxacyclohexacosa-3,17,19,21,23-pentaen-13-carbonsaeure
  • Myprozine
  • BDBM50370755
  • EINECS 231-683-5
  • E-235
  • Pimaricin, from Streptomyces chattanoogensis, >=95% (HPLC)
  • NATAMYCIN (USP MONOGRAPH)
  • DTXCID301163
  • NATAMYCIN (MART.)
  • BDBM50370755
  • NSC-759167
  • 16-(3-Amino-3,6-didesoxy-beta-D-mannopyranosyloxy)-5,6-epoxy-8,12,14-trihydroxy-26-methyl-2,10-dioxo-1-oxacyclohexacosa-3,17,19,21,23-pentaen-13-carbonsaeure
  • NATAMYCIN (USP MONOGRAPH)
  • SCHEMBL18140
  • E-235
  • NSC-759167
  • UNII-8O0C852CPO
  • NATAMYCIN [VANDF]
  • SCHEMBL18140
  • UNII-8O0C852CPO
  • PMR
  • NATAMYCIN [VANDF]
  • (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • PMR
  • Natajen
  • NATAMYCIN [USP-RS]
  • (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
  • NSC 759167
  • Natajen
  • INS NO.235
  • NATAMYCIN [USP-RS]
  • Myprozine
  • NSC 759167
  • Pimaricin, from Streptomyces chattanoogensis, >=95% (HPLC)
  • INS NO.235
  • NATAMYCIN (MART.)
  • Myprozine
  • 16-(3-Amino-3,6-didesoxy-beta-D-mannopyranosyloxy)-5,6-epoxy-8,12,14-trihydroxy-26-methyl-2,10-dioxo-1-oxacyclohexacosa-3,17,19,21,23-pentaen-13-carbonsaeure
  • Pimaricin, from Streptomyces chattanoogensis, >=95% (HPLC)
  • E-235
  • NATAMYCIN (MART.)
  • 16-(3-Amino-3,6-didesoxy-beta-D-mannopyranosyloxy)-5,6-epoxy-8,12,14-trihydroxy-26-methyl-2,10-dioxo-1-oxacyclohexacosa-3,17,19,21,23-pentaen-13-carbonsaeure
  • E-235
  • SMR000466358
  • SMR000466358
  • SMP1_000240
  • SMP1_000240
  • MLS000759475
  • MLS000759475
  • PIMARICIN, STREPTOMYCES CHATTANOOGENSIS
  • PIMARICIN, STREPTOMYCES CHATTANOOGENSIS
物化性质
实验特性
LogP 0.82000
PSA 230.99000
Merck 13,6453
折射率 1.5960 (estimate)
沸点 952.2°C at 760 mmHg
熔点 280-300°C
闪点 >110°(230°F)
溶解度 Soluble in DMSO
颜色与性状 Powder
稳定性 Light sensitive
敏感性 Light Sensitive
比旋光度 +278° (c=1, CH3COOH)
密度 1.0 g/mL at 20 °C(lit.)
计算特性
精确分子量 665.30500
氢键供体数量 7
氢键受体数量 14
可旋转化学键数量 3
同位素质量 665.305
重原子数量 47
复杂度 1220
同位素原子数量 0
确定原子立构中心数量 14
不确定原子立构中心数量 0
确定化学键立构中心数量 5
不确定化学键立构中心数量 0
共价键单元数量 1
疏水参数计算参考值(XlogP) -1.3
拓扑分子极性表面积 231
国际标准相关数据
EINECS 231-683-5
专业数据库参考
PubChemId 5284447
参考资料
Reaxys RN
Beilstein 1614878
化合物详情(旧版)

纳他霉素物理化学性质

熔点: 2000C (dec)
密度: 1.0 g/mL at 20 °C(lit.)
储存条件: 2-8°C
form: aqueous suspension
化学性质:近白色到奶油黄色粉末,几乎无臭无味。可含有3mol的水。熔点280℃(分解)。几不溶于水,微溶于甲醇,溶于冰醋酸和二甲基亚砜。 

纳他霉素产品用途

【用途】  防霉剂。用于霉菌容易增殖的、暴露于空气中的食品表面时,有良好的抗霉效果。用于发酵干酪可选择性地抑制霉菌的繁殖而让细菌得到正常的生长和代谢。该产品应贮存于密封良好、无直射阳光、<15℃下。
【用途】  抗真菌药物。

纳他霉素生产方法

由游链霉菌(Streptomyces natalensis)受控发酵制得。

纳他霉素推荐生产厂家
960化工网为您提供纳他霉素专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:7681-93-8,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等;| WAP 版:7681-93-8
平台客服 平台客服

平台在线客服